Last update 23 Jan 2025

MT-026 (T-Maximum)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
Anti-IL13 receptor alpha-2 CAR-T cell therapy ( Suzhou Maximum Bio-tech), Antiinterleukin13 receptor alpha2 CART cell therapy Maximum Biotech, CAR T cell therapy targeting IL13 receptor alpha2 Maximum Biotech
+ [3]
Target
IL-13Rα2
Mechanism
IL-13Rα2 inhibitors(Interleukin-13 receptor subunit alpha-2 inhibitors), Gene transference, T lymphocyte replacements
Therapeutic Areas
NeoplasmsNervous System Diseases
Active Indication
GliomaBrain metastases
Inactive Indication-
Originator Organization
T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.
Active Organization
T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.Second Affiliated Hospital of Soochow University
Inactive Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MT-026 (T-Maximum)
NCT05752877
/ RecruitingNot ApplicableIIT
Clinical Study on Evaluation of Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T Cell Injection in Treatment of Advanced Glioma
100 Clinical Results associated with MT-026 (T-Maximum)
Login to view more data
100 Translational Medicine associated with MT-026 (T-Maximum)
Login to view more data
100 Patents (Medical) associated with MT-026 (T-Maximum)
Login to view more data
100 Deals associated with MT-026 (T-Maximum)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain metastasesPreclinical
CN
T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.
30 Jan 2022
GliomaDiscovery
CN
T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.T-MAXIMUM Biopharmaceuticals (Suzhou) Co., Ltd.
03 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free